指南与共识系统性红斑狼疮其他结缔组织病

欧洲风湿病学联盟关于系统性红斑狼疮与系统性硬化症非药物管理的推荐意见

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.
指南 / 共识 · Ann Rheum Dis · 2024-05-15

该推荐由欧洲风湿病学联盟(EULAR)工作组制定,基于系统性文献综述形成4项总体原则和12条推荐,覆盖系统性红斑狼疮(SLE)与系统性硬化症(SSc)非药物管理的共性与疾病特异性方面;推荐强度A至D,平均同意度8.4至9.7。推荐强调以人为中心、个体化、参与式的非药物管理,应与药物治疗互补而非替代,涵盖教育、运动、戒烟、避免寒冷暴露、光防护、心理社会干预及口腔与手部锻炼等。

要点

  • SLE与SSc的非药物管理应个体化、以人为中心并鼓励患者参与,与药物治疗互补而非替代。
  • 应向患者提供教育及运动、戒烟、避免寒冷暴露的支持;SLE患者需光防护与心理社会干预,SSc患者需口腔与手部锻炼。
  • 共形成4项总体原则和12条推荐,推荐强度A至D,平均同意度8.4至9.7。

核心结论

  • 该推荐旨在指导医疗专业人员与患者对SLE和SSc实施整体、个体化的管理。
  • 工作组制定了研究与教育议程,以应对提高证据等级、加强医患沟通和改善结局的需求。

研究设计与样本

  • 由7名风湿病学家、15名其他医疗专业人员和3名患者组成工作组。
  • 基于系统性文献综述制定条目,经在线会议讨论,并按EULAR标准操作流程依据偏倚风险评估、证据等级(LoE)和推荐强度(SoR;A-D级,A包含一致的LoE 1研究,D包含LoE 4或不一致研究)进行分级。
  • 每条条目通过在线投票确定同意度(LoA;0-10分,0表示完全不同意,10表示完全同意)。

主要发现

  • 共制定4项总体原则和12条推荐,涉及非药物管理的共性与疾病特异性方面。
  • 推荐强度范围为A至D。
  • 总体原则与推荐的平均同意度范围为8.4至9.7。

关键数值与推荐

  • SLE和SSc的非药物管理应个体化、以人为中心并具参与性,不意图取代药物治疗而是补充药物治疗。
  • 应向患者提供教育及运动、戒烟和避免寒冷暴露的支持。
  • 光防护和心理社会干预对SLE患者重要,口腔和手部锻炼对SSc患者重要。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop evidence-based recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). METHODS: A task force comprising 7 rheumatologists, 15 other healthcare professionals and 3 patients was established. Following a systematic literature review performed to inform the recommendations, statements were formulated, discussed during online meetings and graded based on risk of bias assessment, level of evidence (LoE) and strength of recommendation (SoR; scale A-D, A comprising consistent LoE 1 studies, D comprising LoE 4 or inconsistent studies), following the European Alliance of Associations for Rheumatology standard operating procedure. Level of agreement (LoA; scale 0-10, 0 denoting complete disagreement, 10 denoting complete agreement) was determined for each statement through online voting. RESULTS: Four overarching principles and 12 recommendations were developed. These concerned common and disease-specific aspects of non-pharmacological management. SoR ranged from A to D. The mean LoA with the overarching principles and recommendations ranged from 8.4 to 9.7. Briefly, non-pharmacological management of SLE and SSc should be tailored, person-centred and participatory. It is not intended to preclude but rather complement pharmacotherapy. Patients should be offered education and support for physical exercise, smoking cessation and avoidance of cold exposure. Photoprotection and psychosocial interventions are important for SLE patients, while mouth and hand exercises are important in SSc. CONCLUSIONS: The recommendations will guide healthcare professionals and patients towards a holistic and personalised management of SLE and SSc. Research and educational agendas were developed to address needs towards a higher evidence level, enhancement of clinician-patient communication and improved outcomes.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Parodis I, Girard-Guyonvarc'h C, Arnaud L, et al. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis. 2024. PMID: 37433575. doi:10.1136/ard-2023-224416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。